NIH-Funded Study Unveils Compact CRISPR System for Targeted In-Body Gene Editing
Researchers backed by the National Institutes of Health have developed an enhanced CRISPR enzyme that enables efficient gene editing and fits into viral delivery systems, advancing potential in-body therapies.
Biotechnology Innovation | 15/04/2026 | By News Bureau
Alltrna Receives Approval to Begin First-in-Human Trial of tRNA Therapeutic AP003
Alltrna initiates first-in-human trial of engineered tRNA therapy AP003 in Australia, marking a breakthrough in genetic disease treatment.
Biotechnology Innovation | 01/04/2026 | By News Bureau | 122
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy